Arctic Bioscience AS (FRA:9TD) Research & Development: €0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:9TD Arctic Bioscience AS FRA:9TD
59 GF Score
Price €0.24
GF Value €1.02
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Arctic Bioscience AS Research & Development?

Arctic Bioscience AS FRA:9TD -7.95% 59 Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:9TD with a GF Score™ of 59/100 and a GF Value™ of €1.02 (Possible Value Trap). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Arctic Bioscience AS's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Arctic Bioscience AS  (FRA:9TD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Arctic Bioscience AS Research & Development Related Terms

Arctic Bioscience AS Research & Development Historical Data

* Premium members only.

The historical data trend for Arctic Bioscience AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arctic Bioscience AS Research & Development Chart

Arctic Bioscience AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Arctic Bioscience AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:9TD
59GF Score
Arctic Bioscience AS FRA:9TD
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arctic Bioscience AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Arctic Bioscience AS (FRA:9TD) has a Research & Development of €0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Arctic Bioscience AS and its competitors.
Is Arctic Bioscience AS's Research & Development too high?
Arctic Bioscience AS's current Research & Development is €0.00 Mil. Overall, Arctic Bioscience AS has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arctic Bioscience AS's Research & Development compare to VRTX and REGN?
Arctic Bioscience AS's Research & Development of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Arctic Bioscience AS and its competitors. Arctic Bioscience AS's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arctic Bioscience AS stock overvalued right now?
Based on GuruFocus' analysis, Arctic Bioscience AS (FRA:9TD) is currently considered Possible Value Trap. The stock's GF Value™ is €1.02, compared to a current price of €0.24 — trading 76.2% below its estimated fair value. The current Research & Development is €0.00 Mil. Arctic Bioscience AS's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Arctic Bioscience AS (FRA:9TD), the current Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arctic Bioscience AS (FRA:9TD) Overvalued in 2026?

Based on GuruFocus' analysis, Arctic Bioscience AS stock appears to be undervalued. The current stock price of €0.24 is trading 76.2% below its estimated GF Value™ of €1.02. GuruFocus considers Arctic Bioscience AS to be Possible Value Trap.

Key valuation signals for FRA:9TD:

  • Research & Development: €0.00 Mil
  • GF Value™: €1.02 vs. price of €0.24 (76.2% below fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the FRA:9TD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arctic Bioscience AS Business Description

Other Exchanges ABS:Norway
Address Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. Geographically, the company operates in Norway, the Americas, Europe, and APAC, with the majority of the revenue derived from the Americas.
59GF Score

Get the complete analysis for FRA:9TD

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.24
Price
€1.02
GF Value